What does ARS Pharmaceuticals, Inc. do?
ARS Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes treatments for severe allergic reactions in the United States and internationally. The company is involved in the development of neffy, a needle-free intranasal delivery of epinephrine for emergency treatment of Type I allergic…
What is ARS Pharmaceuticals, Inc.'s P/E and P/B ratio?
ARS Pharmaceuticals, Inc. has a P/E ratio of -2.0 and a P/B ratio of 34.34.
What is ARS Pharmaceuticals, Inc.'s debt-to-equity ratio?
ARS Pharmaceuticals, Inc. has a debt-to-equity ratio of 13.72.
How much does ARS Pharmaceuticals, Inc. owe compared with what it owns?
ARS Pharmaceuticals, Inc. owes $0.95 for every $1 it owns (balance sheet Jun 2026), which is high.
What is ARS Pharmaceuticals, Inc.'s Positivity rank?
ARS Pharmaceuticals, Inc. is ranked #6,312 of 6,775 companies globally and #3,602 of 4,000 in United States on PositoAI, with a Positivity Score of -7,880.
Does ARS Pharmaceuticals, Inc. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?
No active red flags (PosiRed) or yellow flags (PosiYellow) are currently on record for ARS Pharmaceuticals, Inc..
Where can I read the latest news about ARS Pharmaceuticals, Inc.?
Recent headlines about ARS Pharmaceuticals, Inc. from the last 30 days, with links to the original articles, are on its News page on PositoAI.
Does ARS Pharmaceuticals, Inc. have a PositoAI PosiShot or QR code?
Yes. A dated PosiShot of ARS Pharmaceuticals, Inc.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.